The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates
Open accessAbstract
The use of antibody-drug conjugates (ADCs) as a therapeutic platform to treat cancer has recently gained substantial momentum. This therapeutic modality has the potential to increase the efficacy and reduce the systemic toxicity associated with current therapeutic regimens. The efficacy of ADCs, however, relies on the proper exploitation of intracellular sorting dynamics of the antigen as well as the specificity, selectivity and pharmacokinetic properties of the antibody itself. Our understanding of endocytosis and endosomal trafficking of receptors has appreciably increased in recent years, as improvements in the assays used to study these events have resolved many of the molecular mechanisms regulating these processes. As a result, we now have the knowledge necessary to exploit these pathways efficiently to improve the efficacy of antibody-based therapy. This review discusses some recent studies that have explored how endo/lysosomal dynamics can affect the efficacy of engineered therapeutic antibodies, including ADCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Rab GTPases as coordinators of vesicle traffic
Stenmark, H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2728 · Cited by 3,413
Huotari, J., & Helenius, A. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.286 · Cited by 2,265
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
Pathways of clathrin-independent endocytosis
Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
pH and the recycling of transferrin during receptor-mediated endocytosis.
Dautry-Varsat, A., Ciechanover, A., & Lodish, H. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2258 · Cited by 1,179
Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling
Le Roy, C., & Wrana, J. L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1571 · Cited by 871
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., & Birchmeier, W. (2002) · Nature Cell Biology · doi:10.1038/ncb758 · Cited by 846
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
Shenoy, S. K., McDonald, P. H., Kohout, T. A., & Lefkowitz, R. J. (2001) · Science · doi:10.1126/science.1063866 · Cited by 824
Antibody-Drug Conjugates in Cancer Therapy
Sievers, E. L., & Senter, P. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 770
Dynamin Undergoes a GTP-Dependent Conformational Change Causing Vesiculation
Sweitzer, S. M., & Hinshaw, J. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81207-6 · Cited by 680
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.012 · Cited by 624
Erickson, H. K., Park, P. U., Widdison, W. C., Kovtun, Y. V., Garrett, L. M., Hoffman, K., Lutz, R. J., Goldmacher, V. S., & Blättler, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4489 · Cited by 584
A Structural Explanation for the Recognition of Tyrosine-Based Endocytotic Signals
Owen, D. J., & Evans, P. R. (1998) · Science · doi:10.1126/science.282.5392.1327 · Cited by 583
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Schmidt, M. M., & Wittrup, K. D. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0195 · Cited by 576
ADP-Ribosylation Factor 6 Regulates a Novel Plasma Membrane Recycling Pathway
Radhakrishna, H., & Donaldson, J. G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.49 · Cited by 508
GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission
Roux, A., Uyhazi, K., Frost, A., & De Camilli, P. (2006) · Nature · doi:10.1038/nature04718 · Cited by 490
Karin, M., & Mintz, B. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69597-9 · Cited by 488
Kovtun, Y. V., Audette, C. A., Ye, Y., Xie, H., Ruberti, M. F., Phinney, S. J., Leece, B. A., Chittenden, T., Blättler, W. A., & Goldmacher, V. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3973 · Cited by 479
LoRusso, P. M., Weiss, D., Guardino, E., Girish, S., & Sliwkowski, M. X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0762 · Cited by 444
Coordinated Actions of Actin and BAR Proteins Upstream of Dynamin at Endocytic Clathrin-Coated Pits
Ferguson, S., Raimondi, A., Paradise, S., Shen, H., Mesaki, K., Ferguson, A., Destaing, O., Ko, G., Takasaki, J., Cremona, O., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.11.005 · Cited by 442
Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406
Schier, R., McCall, A., Adams, G. P., Marshall, K. W., Merritt, H., Yim, M., Crawford, R. S., Weiner, L. M., Marks, C., & Marks, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0598 · Cited by 382
Stowell, M. H. B., Marks, B., Wigge, P., & McMahon, H. T. (1999) · Nature Cell Biology · doi:10.1038/8997 · Cited by 378
Rudnick, S. I., Lou, J., Shaller, C. C., Tang, Y., Klein-Szanto, A. J. P., Weiner, L. M., Marks, J. D., & Adams, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2277 · Cited by 365
Igawa, T., Ishii, S., Tachibana, T., Maeda, A., Higuchi, Y., Shimaoka, S., Moriyama, C., Watanabe, T., Takubo, R., Doi, Y., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1691 · Cited by 353
Differential effects of EGFR ligands on endocytic sorting of the receptor
Roepstorff, K., Grandal, M. V., Henriksen, L., Knudsen, S. L. J., Lerdrup, M., Grøvdal, L., Willumsen, B. M., & Van Deurs, B. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00943.x · Cited by 310
Characterization of a Nonclathrin Endocytic Pathway: Membrane Cargo and Lipid Requirements
Naslavsky, N., Weigert, R., & Donaldson, J. G. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0151 · Cited by 305
Höning, S., Ricotta, D., Krauss, M., Späte, K., Spolaore, B., Motley, A., Robinson, M., Robinson, C., Haucke, V., & Owen, D. J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.019 · Cited by 301
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1989) · PubMed · Cited by 299
Schier, R., Bye, J., Apell, G., McCall, A., Adams, G. P., Malmqvist, M., Weiner, L. M., & Marks, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0004 · Cited by 292
Naslavsky, N., Weigert, R., & Donaldson, J. G. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-04-0053 · Cited by 278
Amphiphysin Heterodimers: Potential Role in Clathrin-mediated Endocytosis
Wigge, P., Köhler, K., Vallis, Y., Doyle, C. A., Owen, D., Hunt, S. P., & McMahon, H. T. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.10.2003 · Cited by 265
Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level
Ober, R. J., Martinez, C., Lai, X., Zhou, J., & Ward, E. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402970101 · Cited by 258
Polson, A. G., Calemine-Fenaux, J., Chan, P., Chang, W., Christensen, E., Clark, S., de Sauvage, F. J., Eaton, D., Elkins, K., Elliott, J. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2250 · Cited by 252
Zahnd, C., Kawe, M., Stumpp, M. T., de Pasquale, C., Tamaskovic, R., Nagy-Davidescu, G., Dreier, B., Schibli, R., Binz, H. K., Waibel, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2724 · Cited by 245
Hamann, P. R., Hinman, L. M., Beyer, C. F., Lindh, D., Upeslacis, J., Flowers, D. A., & Bernstein, I. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0100206 · Cited by 230
Drug-conjugated monoclonal antibodies for the treatment of cancer
LAMBERT, J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.017 · Cited by 210
Erickson, H. K., Lewis Phillips, G. D., Leipold, D. D., Provenzano, C. A., Mai, E., Johnson, H. A., Gunter, B., Audette, C. A., Gupta, M., Pinkas, J., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0727 · Cited by 194
Pellinen, T., & Ivaska, J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03216 · Cited by 187
Harford, J., Bridges, K., Ashwell, G., & Klausner, R. D. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32848-5 · Cited by 175
SNX–BAR‐Mediated Endosome Tubulation is Co‐ordinated with Endosome Maturation
van Weering, J. R. T., Verkade, P., & Cullen, P. J. (2012) · Traffic · doi:10.1111/j.1600-0854.2011.01297.x · Cited by 169
Chaparro-Riggers, J., Liang, H., DeVay, R. M., Bai, L., Sutton, J. E., Chen, W., Geng, T., Lindquist, K., Casas, M. G., Boustany, L. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.319764 · Cited by 166
Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor.
Harford, J. B., Wolkoff, A. W., Ashwell, G., & Klausner, R. D. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.96.6.1824 · Cited by 156
Löwenberg, B., Beck, J., Graux, C., van Putten, W., Schouten, H. C., Verdonck, L. F., Ferrant, A., Sonneveld, P., Jongen‐Lavrencic, M., von Lilienfeld‐Toal, M., et al. (2010) · Blood · doi:10.1182/blood-2009-10-246470 · Cited by 145
Sundborger, A., Soderblom, C., Vorontsova, O. V., Evergren, E., Hinshaw, J. E., & Shupliakov, O. (2010) · Journal of Cell Science · doi:10.1242/jcs.072686 · Cited by 143
Choudhury, A., Sharma, D. K., Marks, D. L., & Pagano, R. E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0432 · Cited by 140
Molecular mechanisms of late endosome morphology, identity and sorting
Russell, M. R. G., Nickerson, D. P., & Odorizzi, G. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.06.002 · Cited by 128
The Pharmacology of Monoclonal Antibodiesa
Weinstein, J. N., Eger, R. R., Covell, D. G., BLACK, C. D. V., Mulshine, J. L., Carrasquillo, J. A., Larson, S. M., & Keenan, A. M. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb45802.x · Cited by 127
Yamashiro, D. J., & Maxfield, F. R. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.6.2723 · Cited by 123
The next generation of antibody-drug conjugates comes of age.
Beck, A., Haeuw, J., Wurch, T., Goetsch, L., Bailly, C., & Corvaı̈a, N. (2010) · PubMed · Cited by 120
Ellinger, I., Schwab, M., Stefanescu, A., Hunziker, W., & Fuchs, R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<733::aid-immu733>3.0.co;2-c · Cited by 119
Rocca, A., Lamaze, C., Subtil, A., & Dautry‐Varsat, A. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1293 · Cited by 113
Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids
Ackerman, M. E., Pawlowski, D., & Wittrup, K. D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0067 · Cited by 107
Ingle, G. S., Chan, P., Elliott, J. M., Chang, W. S., Koeppen, H., Stéphan, J.-P., & Scales, S. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06883.x · Cited by 83
Constitutive internalization and recycling of metabotropic glutamate receptor 5 (mGluR5)
Trivedi, R. R., & Bhattacharyya, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.040 · Cited by 39
Reddy, S., Shaller, C. C., Doss, M., Shchaveleva, I., Marks, J. D., Yu, J. Q., & Robinson, M. K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1654 · Cited by 38
EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain
Jones, S. M., Foreman, S. K., Shank, B. B., & Kurten, R. C. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2001 · Cited by 35
Kulkarni, M. V., Tettamanzi, M. C., Murphy, J. W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172072 · Cited by 31
The clinical efficacy of tocilizumab in rheumatoid arthritis
Mircic, M., & Kavanaugh, A. (2009) · Drugs of today · doi:10.1358/dot.2009.45.3.1343794 · Cited by 17
Analysis of Site-Specific Histidine Protonation in Human Prolactin,
Tettamanzi, M. C., Keeler, C., Meshack, S., & Hodsdon, M. E. (2008) · Biochemistry · doi:10.1021/bi800444t · Cited by 16
Tanaka, M., Kano, Y., Akutsu, M., Tsunoda, S., Izumi, T., Yazawa, Y., Miyawaki, S., Mano, H., & Furukawa, Y. (2009) · PubMed · Cited by 14
Cited by
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Unlocking the potential of antibody–drug conjugates for cancer therapy
Drago, J. Z., Modi, S., & Chandarlapaty, S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00470-8 · Cited by 1,150
Antibody–drug conjugates for cancer
Chau, C. H., Steeg, P. S., & Figg, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31774-x · Cited by 816
Antibody–Drug Conjugates: A Comprehensive Review
Khongorzul, P., Ling, C. J., Khan, F. U., Ihsan, A. U., & Zhang, J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0582 · Cited by 787
Site-specific antibody drug conjugates for cancer therapy
Panowski, S., Bhakta, S., Raab, H., Polakis, P., & Junutula, J. R. (2014) · mAbs · doi:10.4161/mabs.27022 · Cited by 676
Metadata
- Authors
- Ritchie, M., Tchistiakova, L., & Scott, N.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2013-01
- Volume
- 5
- Issue
- 1
- Pages
- 13-21
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W1966390946
- Cited by
- 312
- References
- 69
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.